Logo image of JRVR

JAMES RIVER GROUP HOLDINGS L (JRVR) Stock Fundamental Analysis

NASDAQ:JRVR - BMG5005R1079 - Common Stock

5.98 USD
+0.16 (+2.75%)
Last: 8/22/2025, 8:19:40 PM
5.98 USD
0 (0%)
After Hours: 8/22/2025, 8:19:40 PM
Fundamental Rating

2

JRVR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 143 industry peers in the Insurance industry. JRVR has a bad profitability rating. Also its financial health evaluation is rather negative. JRVR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year JRVR has reported negative net income.
JRVR had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: JRVR reported negative net income in multiple years.
In multiple years JRVR reported negative operating cash flow during the last 5 years.
JRVR Yearly Net Income VS EBIT VS OCF VS FCFJRVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

JRVR has a worse Return On Assets (-2.50%) than 88.11% of its industry peers.
With a Return On Equity value of -20.08%, JRVR is not doing good in the industry: 90.21% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.5%
ROE -20.08%
ROIC N/A
ROA(3y)-1.38%
ROA(5y)-1.51%
ROE(3y)-11.37%
ROE(5y)-11.47%
ROIC(3y)N/A
ROIC(5y)N/A
JRVR Yearly ROA, ROE, ROICJRVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for JRVR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JRVR Yearly Profit, Operating, Gross MarginsJRVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

JRVR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JRVR has been increased compared to 1 year ago.
JRVR has more shares outstanding than it did 5 years ago.
JRVR has a better debt/assets ratio than last year.
JRVR Yearly Shares OutstandingJRVR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
JRVR Yearly Total Debt VS Total AssetsJRVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

JRVR has a Debt/Equity ratio of 0.53. This is a neutral value indicating JRVR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.53, JRVR is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.77%
JRVR Yearly LT Debt VS Equity VS FCFJRVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
JRVR Yearly Current Assets VS Current LiabilitesJRVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for JRVR have decreased strongly by -185.62% in the last year.
Looking at the last year, JRVR shows a very negative growth in Revenue. The Revenue has decreased by -53.63% in the last year.
JRVR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.85% yearly.
EPS 1Y (TTM)-185.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.3%
Revenue 1Y (TTM)-53.63%
Revenue growth 3Y-2.9%
Revenue growth 5Y-4.85%
Sales Q2Q%-7.14%

3.2 Future

JRVR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.08% yearly.
Based on estimates for the next years, JRVR will show a small growth in Revenue. The Revenue will grow by 1.12% on average per year.
EPS Next Y200.99%
EPS Next 2Y77.12%
EPS Next 3Y47.08%
EPS Next 5YN/A
Revenue Next Year-3.26%
Revenue Next 2Y2.18%
Revenue Next 3Y1.12%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JRVR Yearly Revenue VS EstimatesJRVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
JRVR Yearly EPS VS EstimatesJRVR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

JRVR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 5.21 indicates a rather cheap valuation of JRVR.
JRVR's Price/Forward Earnings ratio is rather cheap when compared to the industry. JRVR is cheaper than 82.52% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.81. JRVR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 5.21
JRVR Price Earnings VS Forward Price EarningsJRVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JRVR Per share dataJRVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

JRVR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JRVR's earnings are expected to grow with 47.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.12%
EPS Next 3Y47.08%

More info and screens

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.69%, JRVR is not a good candidate for dividend investing.
JRVR's Dividend Yield is slightly below the industry average, which is at 3.52.
Compared to an average S&P500 Dividend Yield of 2.34, JRVR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.69%

5.2 History

The dividend of JRVR decreases each year by -17.79%.
JRVR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-17.79%
Div Incr Years0
Div Non Decr Years0
JRVR Yearly Dividends per shareJRVR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of JRVR are negative and hence is the payout ratio. JRVR will probably not be able to sustain this dividend level.
DP-11.82%
EPS Next 2Y77.12%
EPS Next 3Y47.08%
JRVR Yearly Income VS Free CF VS DividendJRVR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

More info and screens

JAMES RIVER GROUP HOLDINGS L

NASDAQ:JRVR (8/22/2025, 8:19:40 PM)

After market: 5.98 0 (0%)

5.98

+0.16 (+2.75%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners62.61%
Inst Owner Change0.28%
Ins Owners2.08%
Ins Owner Change25.15%
Market Cap274.60M
Analysts80
Price Target7.2 (20.4%)
Short Float %4.47%
Short Ratio7.51
Dividend
Industry RankSector Rank
Dividend Yield 0.69%
Yearly Dividend0.46
Dividend Growth(5Y)-17.79%
DP-11.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-15 2025-09-15 (0.01)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.74%
Min EPS beat(2)-30.6%
Max EPS beat(2)-2.89%
EPS beat(4)0
Avg EPS beat(4)-180.96%
Min EPS beat(4)-572.63%
Max EPS beat(4)-2.89%
EPS beat(8)1
Avg EPS beat(8)-97.7%
EPS beat(12)2
Avg EPS beat(12)-64.83%
EPS beat(16)4
Avg EPS beat(16)-146.24%
Revenue beat(2)0
Avg Revenue beat(2)-5.57%
Min Revenue beat(2)-8.27%
Max Revenue beat(2)-2.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.32%
Min Revenue beat(4)-18.23%
Max Revenue beat(4)28.1%
Revenue beat(8)4
Avg Revenue beat(8)6%
Revenue beat(12)7
Avg Revenue beat(12)4.83%
Revenue beat(16)8
Avg Revenue beat(16)2.88%
PT rev (1m)3.67%
PT rev (3m)3.67%
EPS NQ rev (1m)-9.83%
EPS NQ rev (3m)-45.58%
EPS NY rev (1m)8.89%
EPS NY rev (3m)10.74%
Revenue NQ rev (1m)0.83%
Revenue NQ rev (3m)-10.14%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.21
P/S 0.41
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.67
EV/EBITDA N/A
EPS(TTM)-1.31
EYN/A
EPS(NY)1.15
Fwd EY19.21%
FCF(TTM)-6.4
FCFYN/A
OCF(TTM)-6.29
OCFYN/A
SpS14.49
BVpS13.63
TBVpS8.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.5%
ROE -20.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.38%
ROA(5y)-1.51%
ROE(3y)-11.37%
ROE(5y)-11.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.57%
Cap/Sales 0.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score0
WACC7.77%
ROIC/WACCN/A
Cap/Depr(3y)7.66%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.83%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-185.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.3%
EPS Next Y200.99%
EPS Next 2Y77.12%
EPS Next 3Y47.08%
EPS Next 5YN/A
Revenue 1Y (TTM)-53.63%
Revenue growth 3Y-2.9%
Revenue growth 5Y-4.85%
Sales Q2Q%-7.14%
Revenue Next Year-3.26%
Revenue Next 2Y2.18%
Revenue Next 3Y1.12%
Revenue Next 5YN/A
EBIT growth 1Y-135.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1931.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-347.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-329.2%
OCF growth 3YN/A
OCF growth 5YN/A